Breaking News Instant updates and real-time market news.

CELG

Celgene

$104.99

-1.69 (-1.58%)

, BLUE

Bluebird Bio

$175.00

-2.1 (-1.19%)

12:34
01/08/18
01/08
12:34
01/08/18
12:34

Celgene does not need to acquire partners, CEO says

Celgene (CELG) CEO Mark Alles said on CNBC that his company does not need to acquire partners like bluebird bio (BLUE).

CELG

Celgene

$104.99

-1.69 (-1.58%)

BLUE

Bluebird Bio

$175.00

-2.1 (-1.19%)

  • 08

    Jan

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 26

    Feb

  • 25

    Mar

CELG Celgene
$104.99

-1.69 (-1.58%)

01/08/18
PIPR
01/08/18
NO CHANGE
Target $100
PIPR
Neutral
Celgene guidance 'a bit light' on sales, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond views Celgene's preliminary Q4 results as "solid' but says the company's initial 2018 outlook is "a bit light" on revenue. The better than expected earnings outlook looks to be driven by expense management and lower than modeled share count, Raymond tell investors in a research note. He keeps a Neutral rating on Celgene with a $100 price target.
01/08/18
ADAM
01/08/18
NO CHANGE
Target $140
ADAM
Buy
Celgene acquisition has 'interesting' upside potential, says Canaccord
After Celgene announced a deal to acquire Impact Biosciences for up to $7B, including an upfront payment of $1.1B, Canaccord analyst John Newman said the latter's JAK2 asset for myelofibrosis, fedratinib, showed an "interesting" 55% response rate in patients resistant or intolerant to Jakafi, which provides an immediately approvable FDA indication. This "carefully structured transaction" provides Celgene with substantial upside, assuming FDA approval, said Newman, who keeps a Buy rating and $140 price target on Celgene shares.
01/08/18
DBAB
01/08/18
NO CHANGE
Target $110
DBAB
Buy
Celgene deal 'incremental negative' for Incyte, says Deutsche Bank
Deutsche Bank analyst Navin Jacob calls Celgene's (CELG) acquisition of Impact Biomedicines "one step" in the right direction. The analyst estimates Impact's Jak2 inhibitor fedratinib can achieve 20% of peak Jakafi sales in myelofibrosis and polycythemia vera, which translates to $1B. The asset fits Celgene's business and the $2.4B that the company is paying over the next two years "doesn't appear egregious for a commercial ready asset," Jacob tells investors in a research note. The analyst also views Celgene's acquisition as an "incremental negative" for Incyte (INCY). Given direct overlap, any future potential acquisition of Incyte by Celgene has been removed, Jacob contends. He keeps a Hold rating on Celgene with a $110 price target.
01/05/18
BOFA
01/05/18
DOWNGRADE
BOFA
Neutral
Celgene downgraded to Neutral due to limited growth at BofA/Merrill
BofA/Merrill analyst Ying Huang upgraded Neutral from Buy and lowered its price target to $120 from $129 due to lack of catalysts, headwinds from Revlimid competition, and reduced product sales expectations.
BLUE Bluebird Bio
$175.00

-2.1 (-1.19%)

12/21/17
12/21/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Anadarko (APC) assumed with an Overweight at Piper Jaffray. 2. Hasbro (HAS) was initiated with a Buy at B. Riley FBR while Mattel (MAT) was initiated with a Neutral. 3. bluebird bio (BLUE) initiated with a Perform at Oppenheimer. 4. Cree (CREE) initiated with a Neutral at Piper Jaffray. 5. Children's Place (PLCE) and Carter's (CRI) were initiated with a Hold at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/21/17
OPCO
12/21/17
INITIATION
OPCO
Perform
Opco starts bluebird bio at Perform due to 'market premium'
Oppenheimer analyst Mark Breidenbach last night initiated bluebird bio with a Perform rating with no price target. The analyst cites the "market premium" for bluebird's CAR-T pipeline following the acquisition of Kite Pharma as the reason for his neutral stance. He expects bluebird will successfully transition into a commercial-stage company by 2020, but believes the company's internally developed products will address relatively modest markets.
12/20/17
OPCO
12/20/17
INITIATION
OPCO
Perform
bluebird bio initiated with a Perform at Oppenheimer
Oppenheimer started bluebird bio with a Perform rating.
12/18/17
MSCO
12/18/17
NO CHANGE
MSCO
Morgan Stanley sees opportunities in biotech amid 'limited' investor conviction
With clinical catalysts in large-cap Biotechnology limited to only five key Phase III readouts - three of which are from Alexion (ALXN) - investors are describing their 2018 picks in the space as the "least worst" of the group, according to Morgan Stanley analyst Matthew Harrison. However, he believes this lack of conviction creates real opportunity for outsized moves in 2018, with Amgen (AMGN) identified by Harrison as the biggest potential beneficiary of M&A given "its likely newfound access" to about $39B in offshore cash. Other biotech names the analyst highlights on the up side include Biogen (BIIB), BioMarin (BMRN), Biohaven (BHVN) and Sarepta (SRPT). Meanwhile, Harrison highlights his concerns about potential downside for BioVerativ (BIVV) and Innoviva (INVA), on both of which he keeps Underweight ratings.

TODAY'S FREE FLY STORIES

SNPS

Synopsys

$90.29

1.05 (1.18%)

21:14
05/23/18
05/23
21:14
05/23/18
21:14
Recommendations
Synopsys analyst commentary at JPMorgan »

Synopsys benefited from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AMZN

Amazon.com

$1,601.77

19.67 (1.24%)

21:04
05/23/18
05/23
21:04
05/23/18
21:04
Periodicals
Amazon Web Services to invest in Chile as part of LatAm expansion, Reuters says »

Amazon Web Services is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

SRRK

Scholar Rock

$0.00

(0.00%)

21:01
05/23/18
05/23
21:01
05/23/18
21:01
Syndicate
Scholar Rock 5.36M share IPO priced at $14.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

KNSA

Kiniksa

$0.00

(0.00%)

21:00
05/23/18
05/23
21:00
05/23/18
21:00
Syndicate
Kiniksa 8.5M share IPO priced at $18.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

GSKY

GreenSky

$0.00

(0.00%)

20:58
05/23/18
05/23
20:58
05/23/18
20:58
Syndicate
GreenSky 38M share IPO priced at $23.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

SAIL

SailPoint

$23.30

1.29 (5.86%)

20:56
05/23/18
05/23
20:56
05/23/18
20:56
Syndicate
SailPoint 17.808M share Secondary priced at $22.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

CLPS

CLPS

$0.00

(0.00%)

20:55
05/23/18
05/23
20:55
05/23/18
20:55
Syndicate
CLPS 2M share IPO priced at $5.25 »

The deal priced between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MDT

Medtronic

$85.29

0.305 (0.36%)

, MCK

McKesson

$146.84

0.39 (0.27%)

20:25
05/23/18
05/23
20:25
05/23/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$85.29

0.305 (0.36%)

MCK

McKesson

$146.84

0.39 (0.27%)

BBY

Best Buy

$75.73

0.255 (0.34%)

HRL

Hormel Foods

$35.82

-0.01 (-0.03%)

TTC

Toro Company

$60.32

-0.08 (-0.13%)

SAFM

Sanderson Farms

$107.13

1.19 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

BPOP

Popular

$46.94

-0.31 (-0.66%)

20:07
05/23/18
05/23
20:07
05/23/18
20:07
Hot Stocks
Popular announces early termination of FDIC shared-loss agreements »

Popular, Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

20:04
05/23/18
05/23
20:04
05/23/18
20:04
Recommendations
Williams-Sonoma analyst commentary at Loop Capital »

Williams-Sonoma earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

EWY

iShares MSCI South Korea Index Fund

$74.45

0.73 (0.99%)

, SPY

SPDR S&P 500 ETF Trust

$273.37

0.8 (0.29%)

19:59
05/23/18
05/23
19:59
05/23/18
19:59
Periodicals
Breaking Periodicals news story on iShares MSCI South Korea Index Fund, SPDR S&P 500 ETF Trust, S&P 500 »

N Korea foreign ministry…

EWY

iShares MSCI South Korea Index Fund

$74.45

0.73 (0.99%)

SPY

SPDR S&P 500 ETF Trust

$273.37

0.8 (0.29%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$128.70

0.465 (0.36%)

19:39
05/23/18
05/23
19:39
05/23/18
19:39
Hot Stocks
Canadian court affirms dismissal of suit against Chevron subsidiary »

The Ontario Court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$133.49

1.31 (0.99%)

19:19
05/23/18
05/23
19:19
05/23/18
19:19
Hot Stocks
Electronic Arts CTO sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.67

-0.39 (-0.60%)

19:14
05/23/18
05/23
19:14
05/23/18
19:14
Periodicals
Carnival CEO expects China to become the largest cruise market, CNBC says »

In an interview with CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

PBR

Petrobras

$15.10

-0.6 (-3.82%)

19:11
05/23/18
05/23
19:11
05/23/18
19:11
Periodicals
Petrobras slashes diesel price 10% to resolve trucker protest, Reuters says »

Petrobras has opted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$88.94

-0.24 (-0.27%)

19:05
05/23/18
05/23
19:05
05/23/18
19:05
Hot Stocks
Sarepta granted orphan status for DMD treatment golodirsen »

The FDA granted Sarepta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BZLFF

Bunzl

$0.00

(0.00%)

19:03
05/23/18
05/23
19:03
05/23/18
19:03
Downgrade
Bunzl rating change at Goldman Sachs »

Bunzl downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WUBA

58.com

$84.56

1.39 (1.67%)

19:02
05/23/18
05/23
19:02
05/23/18
19:02
Earnings
Breaking Earnings news story on 58.com »

58.com sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 10

    Sep

WUBA

58.com

$84.56

1.39 (1.67%)

19:01
05/23/18
05/23
19:01
05/23/18
19:01
Earnings
58.com reports Q1 adjusted earnings per ADS 33c, consensus 21c »

Reports Q1 revenue $393M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 10

    Sep

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

, LASR

nLight

$30.00

-1.79 (-5.63%)

18:58
05/23/18
05/23
18:58
05/23/18
18:58
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

LASR

nLight

$30.00

-1.79 (-5.63%)

SNPS

Synopsys

$90.29

1.05 (1.18%)

LB

L Brands

$34.05

0.06 (0.18%)

NTAP

NetApp

$66.61

-0.41 (-0.61%)

DGLY

Digital Ally

$2.55

-0.075 (-2.86%)

FCAU

Fiat Chrysler

$22.47

-0.155 (-0.69%)

TM

Toyota

$134.85

-0.89 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 11

    Jun

  • 12

    Jun

  • 10

    Jul

CPRT

Copart

$52.93

-0.06 (-0.11%)

18:54
05/23/18
05/23
18:54
05/23/18
18:54
Earnings
Copart reports Q3 adjusted EPS 52c, consensus 50c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

AAPL

Apple

$188.36

1.08 (0.58%)

, VLKAY

Volkswagen

$0.00

(0.00%)

18:45
05/23/18
05/23
18:45
05/23/18
18:45
Periodicals
Apple signs pact with VW over self-driving cars, NY Times says »

Apple (AAPL) has signed…

AAPL

Apple

$188.36

1.08 (0.58%)

VLKAY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

18:24
05/23/18
05/23
18:24
05/23/18
18:24
Periodicals
Breaking Periodicals news story on Petrobras »

Petrobras under scrutiny…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$344.70

13.08 (3.94%)

, CMCSA

Comcast

$31.87

-0.64 (-1.97%)

18:03
05/23/18
05/23
18:03
05/23/18
18:03
Periodicals
Netflix market value now higher than Comcast, Recode says »

Netflix's (NFLX)…

NFLX

Netflix

$344.70

13.08 (3.94%)

CMCSA

Comcast

$31.87

-0.64 (-1.97%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$113.87

-0.05 (-0.04%)

18:01
05/23/18
05/23
18:01
05/23/18
18:01
Hot Stocks
Celanese to increase selling prices on acetyl intermediate products »

To raise prices on Vinyl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.